Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Akebia, Angel, Antengene, Axcella Health, Bharat Biotech International, Biontech, China Oncology Focus, Cocrystal, Coherus, Corvus, Gannex, Immunoforge, Immutep, Impact, Junshi, Merck, Moderna, Novavax, Ocugen, Oramed, Pfizer, RDIF, Recce, Ridgeback, Serum Institute of India, Serum Life Sciences, Sorrento, TFF, Vitti Labs.